Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 20

Sort by

Sort Order Select

Journal Articles

Incidence of Varicella Zoster Virus (VZV) and Herpes Simplex Virus (HSV) Infections and Use of Prophylaxis in Lenalidomide-Treated Multiple Myeloma (MM) Patients (pts): An Analysis of MM Trials

Dianna Gary, BSN, Lilia Weiss, MD, Zhinuan Yu, PhD, Qiang Xu, PhD, Neil Minton, MD, David Gillen, MD, Axel Glasmacher, MD, John Freeman, MSc, BSc, JD

Blood (2014) 124 (21): 3451.

https://doi.org/10.1182/blood.V124.21.3451.3451

Published: 2014

Journal Articles

Lenalidomide Treatment Is Not Related to AML Progression Risk but Is Associated with a Survival Benefit in RBC Transfusion-Dependent Patients with IPSS Low- or Int-1-Risk MDS with del5q: Results From a Comparative Study

Andrea Kuendgen, MD, Michael Lauseker, Alan F. List, MD, Pierre Fenaux, MD, PhD, Aristoteles Giagounidis, MD, Nancy Brandenburg, PhD, Jay Backstrom, MD, Axel Glasmacher, MD, Joerg Hasford, MD, Ulrich Germing, MD, On behalf of the International Working Group on MDS with del5q

Blood (2011) 118 (21): 119.

https://doi.org/10.1182/blood.V118.21.119.119

Published: 2011

Journal Articles

Comparative Effectiveness of Bisphoshonates In Multiple Myeloma

Rahul Mhaskar, MD, MPH, Jasmina Redzepovic, Keith Wheatley, Otavio Clark, Axel Glasmacher, MD, Branko Miladinovic, PhD, Ambuj Kumar, MD, MPH, Benjamin Djulbegovic, MD, PhD

Blood (2010) 116 (21): 3028.

https://doi.org/10.1182/blood.V116.21.3028.3028

Published: 2010

Journal Articles

Outcome of Fungal Infection in Patients Undergoing Myelosuppressive Chemotherapy in a Tertiary Care Centre During 12 Years (1995-2006).

Marie von Lilienfeld-Toal, MD, Axel Glasmacher, MD, Günter Marklein, MD, Peter Brossart, MD, Corinna Hahn-Ast, PhD

Blood (2009) 114 (22): 1384.

https://doi.org/10.1182/blood.V114.22.1384.1384

Published: 2009

Journal Articles

Bisphosphonates in Multiple Myeloma. A Systematic Review and Meta Analysis.

Rahul Suresh Mhaskar, MPH, Jasmina Redzepovic, PhD, Keith Wheatley, DPhil, Otavio Clark, MD, PhD, Axel Glasmacher, MD, Ambuj Kumar, MD, MPH, Benjamin Djulbegovic, MD, PhD

Blood (2009) 114 (22): 3858.

https://doi.org/10.1182/blood.V114.22.3858.3858

Published: 2009

Journal Articles

Long-Term Disease Control in Patients with Primary Central Nervous System Lymphoma

Blood (2008) 112 (11): 3600.

https://doi.org/10.1182/blood.V112.11.3600.3600

Published: 2008

Journal Articles

Tandem Versus Single Autologous Hematopoietic Cell Transplantation for Treatment of Multiple Myeloma: A Meta-Analysis of Randomized Controlled Trials (RCT).

Ambuj Kumar, MD, MPH, Mohamed A. Kharfan-Dabaja, MD, Axel Glasmacher, MD, Benjamin Djulbegovic, MD, PhD

Blood (2007) 110 (11): 936.

https://doi.org/10.1182/blood.V110.11.936.936

Published: 2007

Journal Articles

Early Relapses in Primary CNS Lymphoma (PCNSL) without Intraventricular Treatment.

Ingo G.H. Schmidt-Wolf, MD, Hendrick Pels, MD, Annika Jurgens, MD, Axel Glasmacher, MD, Holger Schulz, MD, Andreas Engert, MD, Michael Linnebank, MD, Gabriele Schackert, MD, Heinz Reichmann, MD, Frank Kroschinsky, MD, Marlies Vogt-Schaden, MD, Gertlinde Egerer, MD, Carlo Schaller, MD, Monika Lamprecht, MD, Ulrich Bogdahn, MD, Martina Deckert, MD, Rolf Fimmers, MD, Christoph Bangard, MD, Uwe Schlegel, MD

Blood (2007) 110 (11): 4440.

https://doi.org/10.1182/blood.V110.11.4440.4440

Published: 2007

Journal Articles

Multicenter Phase II Trial of Patients with Refractory or Recurrent Multiple Myeloma with Oral Treatment of Thalidomide Combined with Oral Cyclophosphamide, Idarubicin and Dexamethasone.

Axel Glasmacher, MD, Thomas Moehler, MD, Hartmut Goldschmidt, MD, Thomas Geer, MD, Rolf Kleinschmidt, MD, Tobias Gaska, MD, Janssens Uwe, MD, Jorg Schubert, MD, Patrick Bruck, MD, Michael R. Clemens, MD, Wolfgang Bair, MD, Gernot Seipelt, MD, Michael Schleuning, MD, Corinna Hahn-Ast, PhD, Susanne Herz, Marie von Lilienfeld-Toal, MD, Ralf Naumann, MD, Marcus Gorschluter, MD, Ingo G.H. Schmidt-Wolf, MD

Blood (2007) 110 (11): 4825.

https://doi.org/10.1182/blood.V110.11.4825.4825

Published: 2007

Journal Articles

Multicenter Phase II Trial of Patients with Refractory or Recurrent Multiple Myeloma with Oral Treatment of Thalidomide Combined with Oral Cyclophosphamide, Idarubicin and Dexamethasone.

Ingo G.H. Schmidt-Wolf, MD, Thomas Moehler, MD, Hartmut Goldschmidt, MD, Thomas Geer, MD, Rolf Kleinschmidt, MD, Tobias Gaska, MD, Uwe Janssens, MD, Joerg Schubert, MD, Patrick Brueck, MD, Michael R. Clemens, MD, Wolfgang Bair, MD, Gernot Seipelt, MD, Michael Schleuning, MD, Corinna Hahn-Ast, Ph.D., Susanne Herz, Ph.D., Marie von Lilienfeld-Toal, M.D., Ralph Naumann, MD, Marcus Gorschlueter, MD, Axel Glasmacher, MD

Blood (2006) 108 (11): 3559.

https://doi.org/10.1182/blood.V108.11.3559.3559

Published: 2006

Journal Articles

Necessity of Intraventricular Chemotherapy with the Modified Bonn Protocol in Primary CNS Lymphoma (PCNSL) Patients.

Ingo G.H. Schmidt-Wolf, MD, Hendrik Pels, MD, Annika Juergens, MD, Axel Glasmacher, MD, Holger Schulz, MD, Frank Kroschinsky, MD, Gertlinde Egerer, MD, Monika Lamprecht, MD, Caecilia Wismeth, MD, Uwe Schlegel, MD

Blood (2006) 108 (11): 2452.

https://doi.org/10.1182/blood.V108.11.2452.2452

Published: 2006

Journal Articles

Phase II Trial of the Bonn Polychemotherapy Protocol with Deferred Radiotherapy in Patients with Primary Central Nervous System Lymphoma.

Ingo G.H. Schmidt-Wolf, MD, Annika Juergens, MD, Hendrik Pels, MD, Axel Glasmacher, MD, Holger Schulz, MD, Andreas Engert, MD, Michael Linnebank, MD, Heinz Reichmann, MD, Frank Kroschinsky, MD, Marlies Vogt-Schaden, MD, Gerlinde Egerer, MD, Klaus Fliessbach, MD, Uwe Schlegel, MD

Blood (2006) 108 (11): 2453.

https://doi.org/10.1182/blood.V108.11.2453.2453

Published: 2006

Journal Articles

Itraconazole for Antifungal Prophylaxis in Neutropenic Patients: An Update of a Meta-Analysis with Now 3846 Patients.

Axel Glasmacher, MD, Corinna Hahn, PhD, Marie von Lilienfeld-Toal, MD, Katjana Orlopp, MD, Ingo Schmidt-Wolf, MD, Archie Prentice, MD

Blood (2005) 106 (11): 3224.

https://doi.org/10.1182/blood.V106.11.3224.3224

Published: 2005

Journal Articles

Cost-Effectiveness of Itraconazole for the Prophylaxis of Invasive Fungal Infections for Neutropenic Patients; a Study for 3 European Countries.

Maarten J. Postma, PhD, Robin de Vries, MSc, Harriet Christopherson, MSc, Sarah Howells, MSc, Keith Tolley, MSc, Simon Daenen, MD, Axel Glasmacher, MD, Archibald Prentice, MD, Angela Christie

Blood (2005) 106 (11): 3133.

https://doi.org/10.1182/blood.V106.11.3133.3133

Published: 2005

Journal Articles

Thalidomide in Relapsed or Refractory Patients with Multiple Myeloma: Monotherapy or Combination Therapy? A Report from Systematic Reviews.

Axel Glasmacher, MD, Corinna Hahn, PhD, Florian Hoffmann, Kerstin Furkert, Marie von Lilienfeld-Toal, MD, Katjana Orlopp, MD, Ralph Naumann, MD, Hartmut Goldschmidt, MD, Ingo G.H. Schmidt-Wolf, MD, Marcus Gorschlueter, MD

Blood (2005) 106 (11): 5125.

https://doi.org/10.1182/blood.V106.11.5125.5125

Published: 2005

Journal Articles

All-Trans Retinoic Acid and Gemtuzumab Ozogamicin as Adjunct To Salvage Therapy in Primary Refractory Acute Myeloid Leukemia: Results of Consecutive Phase II Studies of the AMLSG.

Blood (2005) 106 (11): 1849.

https://doi.org/10.1182/blood.V106.11.1849.1849

Published: 2005

Journal Articles

Subtype Adjusted Therapy Improves Outcome of Elderly Patients with Acute Lymphoblastic Leukemia (ALL).

Dieter Hoelzer, MD, PhD, Nicola Goekbuget, MD, Joachim Beck, MD, Thomas Burmeister, MD, Aristoteles Giagounidis, MD, Axel Glasmacher, MD, Heike Pfeifer, MD, Harald Rieder, MD, Mathias Schmid, MD, Eckhard Thiel, MD, PhD, Barbara Wassmann, MD, Oliver Ottmann, MD, PhD

Blood (2004) 104 (11): 2732.

https://doi.org/10.1182/blood.V104.11.2732.2732

Published: 2004

Journal Articles

Chromosome Aberrations in 130 Patients with Multiple Myeloma Detected by Interphase FISH and Their Diagnostic and Prognostic Relevance.

Axel Glasmacher, MD, Corinna Hahn, Ph.D., Andrea Juttner, Regine Schubert, Barbara Busert, Gesa Schwanitz, MD, Ingo G.H. Schmidt-Wolf, MD

Blood (2004) 104 (11): 4938.

https://doi.org/10.1182/blood.V104.11.4938.4938

Published: 2004

Journal Articles

Polychemotherapy in patients with primary CNS lymphoma.

Axel Glasmacher, MD, Hendrik Pels, MD, Christoph Helmstaedter, MD, Martina Deckert, MD, Frank Kroschinsky, MD, Gabriele Schackert, MD, Heinz Reichmann, MD, Gerlinde Egerer, MD, Anthony Ho, MD, Holger Schulz, MD, Andreas Engert, MD, Volker Diehl, MD, Udo Bode, MD, Thomas Klockgether, MD, Uwe Schlegel, MD, Ingo G.H. Schmidt-Wolf, MD

Blood (2004) 104 (11): 3304.

https://doi.org/10.1182/blood.V104.11.3304.3304

Published: 2004

NARROW

Incidence of Varicella Zoster Virus (VZV) and Herpes Simplex Virus (HSV) Infections and Use of Prophylaxis in Lenalidomide-Treated Multiple Myeloma (MM) Patients (pts): An Analysis of MM Trials

Lenalidomide Treatment Is Not Related to AML Progression Risk but Is Associated with a Survival Benefit in RBC Transfusion-Dependent Patients with IPSS Low- or Int-1-Risk MDS with del5q: Results From a Comparative Study

Comparative Effectiveness of Bisphoshonates In Multiple Myeloma

Outcome of Fungal Infection in Patients Undergoing Myelosuppressive Chemotherapy in a Tertiary Care Centre During 12 Years (1995-2006).

OPTIMUM Dose of Thalidomide for Relapsed Multiple Myeloma.

Bisphosphonates in Multiple Myeloma. A Systematic Review and Meta Analysis.

Long-Term Disease Control in Patients with Primary Central Nervous System Lymphoma

Tandem Versus Single Autologous Hematopoietic Cell Transplantation for Treatment of Multiple Myeloma: A Meta-Analysis of Randomized Controlled Trials (RCT).

Early Relapses in Primary CNS Lymphoma (PCNSL) without Intraventricular Treatment.

Multicenter Phase II Trial of Patients with Refractory or Recurrent Multiple Myeloma with Oral Treatment of Thalidomide Combined with Oral Cyclophosphamide, Idarubicin and Dexamethasone.

Multicenter Phase II Trial of Patients with Refractory or Recurrent Multiple Myeloma with Oral Treatment of Thalidomide Combined with Oral Cyclophosphamide, Idarubicin and Dexamethasone.

Necessity of Intraventricular Chemotherapy with the Modified Bonn Protocol in Primary CNS Lymphoma (PCNSL) Patients.

Phase II Trial of the Bonn Polychemotherapy Protocol with Deferred Radiotherapy in Patients with Primary Central Nervous System Lymphoma.

Itraconazole for Antifungal Prophylaxis in Neutropenic Patients: An Update of a Meta-Analysis with Now 3846 Patients.

Cost-Effectiveness of Itraconazole for the Prophylaxis of Invasive Fungal Infections for Neutropenic Patients; a Study for 3 European Countries.

Thalidomide in Relapsed or Refractory Patients with Multiple Myeloma: Monotherapy or Combination Therapy? A Report from Systematic Reviews.

All-Trans Retinoic Acid and Gemtuzumab Ozogamicin as Adjunct To Salvage Therapy in Primary Refractory Acute Myeloid Leukemia: Results of Consecutive Phase II Studies of the AMLSG.

Subtype Adjusted Therapy Improves Outcome of Elderly Patients with Acute Lymphoblastic Leukemia (ALL).

Chromosome Aberrations in 130 Patients with Multiple Myeloma Detected by Interphase FISH and Their Diagnostic and Prognostic Relevance.

Polychemotherapy in patients with primary CNS lymphoma.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only